We are proud to announce that the id.DRIVE partnership has officially recruited 25,000 patients across our three studies (surveillance, COVID-19 and RSV […]
Author: Gert Verbeken
Effectiveness of the AZD1222 Vaccine against COVID-19 hospitalisation in Europe: Final results from the COVIDRIVE test-negative case-control study.
Leonie de Munter, Wilhelmine Meeraus, Akshat Dwivedi, Marianna Mitratza, Chloé Wyndham-Thomas, Lucy Carty, Mario Ouwens, Wendy Hartig-Merkel, Laura Drikite, Griet […]
Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVEplatform.
Jennifer L. Nguyen, Marianna Mitratza, Hannah R. Volkman, Leonie de Munter, Thao Mai Phuong Tran, Catia Marques, Mustapha Mustapha, Srinivas […]
Protection against COVID-19 hospitalisation conferred by primary-series vaccination with AZD1222 in non-boosted individuals: first vaccine effectiveness results of the European COVIDRIVE study and meta-regression analysis.
Wilhelmine Meeraus, Leonie de Munter, Christen M. Gray, Akshat Dwivedi, Chloé Wyndham-Thomas, Mario Ouwens, Wendy Hartig-Merkel, Laura Drikite, Griet Rebry, […]
Durability of the BNT162b2 XBB.1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform” (pre-print).
HR Volkman, L de Munter, JL Nguyen, TMP Tran, M Mitratza, C Marques, L Choi, S Valluri, J Yang, A […]
The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE – a European initiative
Díez-Domingo J, Torcel-Pagnon L, Carmona A, Launay O, Dos Santos G, Rizzo C, Haag M, Stuurman A, Nauta J, Vannacci […]
The id.DRIVE partnership starts a viral respiratory infections surveillance study in adults hospitalised for severe acute respiratory infection in Europe
We are thrilled to announce that we started in July 2024 the id.DRIVE surveillance study in Europe. The surveillance study […]